Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.80
4.15%
After-hours: Aug 15, 2025, 06:53 PM EDT

Cartesian Therapeutics Statistics

Share Statistics

Cartesian Therapeutics has 25.95M shares outstanding. The number of shares has increased by 21.35% in one year.

25.95M
21.35%
0.18%
25.41%
8.33M
214
0.31%

Short Selling Information

The latest short interest is 2.6M, so 10.01% of the outstanding shares have been sold short.

2.6M
10.01%
25.23%
31.41

Valuation Ratios

The PE ratio is -5.99 and the forward PE ratio is -2.81. Cartesian Therapeutics's PEG ratio is 0.06.

-5.99
-2.81
11.92
545.8
-68.21
-14.16
0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cartesian Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 9.43, with a Debt / Equity ratio of -2.06.

9.43
9.43
-2.06
-0.18
-0.43
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$589.59K
$-1.17M
66
0.09
n/a

Taxes

287K
-0.37%

Stock Price Statistics

The stock price has increased by -13.39% in the last 52 weeks. The beta is 0.43, so Cartesian Therapeutics's price volatility has been higher than the market average.

0.43
-13.39%
11.44
15.36
36.53
69,461

Income Statement

In the last 12 months, Cartesian Therapeutics had revenue of 38.91M and earned -77.42M in profits. Earnings per share was -2.99.

38.91M
38.91M
-43.9M
-77.42M
-77.14M
-77.14M
-2.99
Full Income Statement

Balance Sheet

The company has 212.61M in cash and 13.98M in debt, giving a net cash position of 198.63M.

212.61M
13.98M
198.63M
-692.07M
388.89M
151.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.67M and capital expenditures -9.09M, giving a free cash flow of -32.77M.

-23.67M
-9.09M
-32.77M
-1.26
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -112.81% and -198.97%.

100%
-112.81%
-198.23%
-198.97%
-198.23%
-112.81%
-84.21%

Dividends & Yields

RNAC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RNAC is $40, which is 263.6% higher than the current price. The consensus rating is "Buy".

$40
263.6%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Apr 5, 2024. It was a backward split with a ratio of 1:30.

Apr 5, 2024
backward
1:30

Scores

-2.27
2